Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMUS002: FOLFOX-A vs AG in Pancreatic Cancer
NCT04176952Phase 2Terminated
- Start
- Mar 2019
- Primary completion
- Aug 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, paclitaxel in pancreatic ductal adenocarcinoma (PDAC). Started Mar 2019; status: terminated.
02
Drugs
oxaliplatinfluorouracilpaclitaxel
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04176952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04176952.